Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Subclinical Hypothyroidism Diagnosis and Management

Definition and Prevalence

  • Subclinical hypothyroidism is defined as an elevated serum TSH concentration with normal free T4 levels, affecting approximately 4-8.5% of the general adult population without known thyroid disease, with a higher prevalence in women and increasing with age, up to 20% of women over 60 years 1, 3, 4
  • The condition is more common in women than men and less prevalent in blacks compared to whites 4

Risk Factors and Progression

  • Risk factors for subclinical hypothyroidism include previous hyperthyroidism, type 1 diabetes mellitus, family history of thyroid disease, and previous head and neck radiation, with approximately 2-5% of patients progressing to overt hypothyroidism annually 4
  • The risk of progression is higher in patients with higher baseline TSH levels and positive thyroid peroxidase (TPO) antibodies 4

Special Considerations

  • In patients with both adrenal insufficiency and hypothyroidism, steroid treatment should always precede thyroid hormone replacement to avoid precipitating an adrenal crisis 5
  • Beta-blockers may mask some symptoms of thyroid dysfunction, and consideration of endocrinology consultation is recommended for complex cases or when standard therapy fails 5

Pitfalls in Interpretation

  • TSH values between 2.5-4.5 mIU/L may represent early hypothyroidism in some individuals but could also be due to technical issues with the TSH assay, abnormal TSH isoforms, or heterophilic antibodies, and TSH secretion can be affected by conditions other than thyroid dysfunction, requiring careful interpretation 1, 2, 3, 6
  • Repeat thyroid function tests are recommended for confirmation of persistent dysfunction over 3-6 months before initiating treatment, unless TSH > 10 mIU/L 6, 7